Authors:
KASIMIRBAUER S
OTTINGER H
MEUSERS P
BEELEN DW
BRITTINGER G
SEEBER S
SCHEULEN ME
Citation: S. Kasimirbauer et al., IN ACUTE MYELOID-LEUKEMIA, COEXPRESSION OF AT LEAST 2 PROTEINS, INCLUDING P-GLYCOPROTEIN, THE MULTIDRUG RESISTANCE-RELATED PROTEIN, BCL-2, MUTANT P53, AND HEAT-SHOCK-PROTEIN-27, IS PREDICTIVE OF THE RESPONSE TO INDUCTION CHEMOTHERAPY, Experimental hematology, 26(12), 1998, pp. 1111-1117
Authors:
BUNDA V
BEELEN DW
BASU O
KREMENS B
SCHAEFER UW
Citation: V. Bunda et al., TRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELLS FROM MATCHED UNRELATEDDONORS, Bone marrow transplantation, 21, 1998, pp. 23-23
Authors:
ELMAAGACLI AH
BEELEN DW
KROLL M
TRZENSKY S
STEIN C
SCHAEFER UW
Citation: Ah. Elmaagacli et al., DETECTION OF CBF-BETA MYH11 FUSION TRANSCRIPTS IN PATIENTS WITH INV(16) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION/, Bone marrow transplantation, 21(2), 1998, pp. 159-166
Authors:
BEELEN DW
BECKS HW
ELMAAGACLI A
SCHEULEN B
SCHAEFER UW
Citation: Dw. Beelen et al., A RANDOMIZED COMPARISON OF ALLOGENEIC BMT WITH OR WITHOUT DONOR G-CSFPRETREATMENT TO ALLOGENEIC PBSCT IN LEUKEMIA PATIENTS HAVING PARTIALLY HLA-MATCHED EXTENDED FAMILY DONORS (EFD), Bone marrow transplantation, 21, 1998, pp. 103-103
Citation: Ah. Elmaagacli et al., A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 236-236
Authors:
SCHULTEWOLTER T
OTTINGER HD
BEELEN DW
WAGNER SN
SCHAEFER UW
GROSSEWILDE H
GOOS M
Citation: T. Schultewolter et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) ALTERS THE CYTOKINE-PATTERN IN HUMAN T-CELLS IN-VIVO, Journal of investigative dermatology, 110(4), 1998, pp. 656-656
Authors:
KRUGER K
JOCHUM C
GLUSENKAMP KH
KRUSEMANN C
LORENZ P
EBERLEADAMKIEWICZ G
DROSDZIOK W
BEELEN DW
COENEN HH
RAJEWSKY MF
Citation: K. Kruger et al., NEW MODULAR DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC PRE-TARGETING USING TAUTOMER-SPECIFIC MONOCLONAL-ANTIBODY EM-6-47 AND 3-SUBSTITUTED ADENINES, International journal of cancer, 77(4), 1998, pp. 610-619
Authors:
OTTINGER HD
ALBERT E
ARNOLD R
BEELEN DW
BLASCZYK R
BUNJES D
BURDACH S
EBELL W
EHNINGER G
EINSELE H
ENCZMANN J
FAUSER A
FRIEDRICH W
FINKE J
GOBEL U
GOLDMANN SF
GRAMATZKI M
HELBIG W
KANZ L
KLINGSBIEL T
KOLB HJ
KUHNL P
LOLIGER C
MULLER CR
MULLER CA
NIETHAMMER D
SCHAEFER UW
SAYER H
SCHMITZ N
SCHULZERATH R
WASSMUTH R
WERNET P
WESTPHAL E
ZANDER R
ZINTL F
GROSSEWILDE H
Citation: Hd. Ottinger et al., GERMAN CONSENSUS ON IMMUNOGENETIC DONOR SEARCH FOR TRANSPLANTATION OFALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 20(2), 1997, pp. 101-105
Citation: Ah. Elmaagacli et al., A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(12), 1997, pp. 1045-1055
Authors:
ELMAAGACLI AH
BEELEN DW
STOCKOVA J
TRZENSKY S
KROLL M
SCHAEFER UW
STEIN C
OPALKA B
Citation: Ah. Elmaagacli et al., DETECTION OF AML1 ETO FUSION TRANSCRIPTS IN PATIENTS WITH T(8-21) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION/, Blood, 90(8), 1997, pp. 3230-3231
Authors:
BEELEN DW
OTTINGER HD
ELMAAGACLI A
SCHEULEN B
BASU O
KREMENS B
HAVERS W
GROSSEWILDE H
SCHAEFER UW
Citation: Dw. Beelen et al., TRANSPLANTATION OF FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS FROM HLA-IDENTICAL SIBLING OR ALTERNATIVE FAMILY DONORS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES - A PROSPECTIVE COMPARISON ON CLINICAL OUTCOME, IMMUNE RECONSTITUTION, AND HEMATOPOIETIC CHIMERISM, Blood, 90(12), 1997, pp. 4725-4735
Authors:
OTTINGER HD
BEELEN DW
KASIMIRBAUER S
SCHULTEWOLTER T
REBMANN V
GOOS M
SCHEULEN ME
SEEBER S
SCHAEFER UW
GROSSEWILDE H
KLOKE O
Citation: Hd. Ottinger et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) REDUCES THE CAPACITY OFT-CELLS TO EXPRESS PRO-INFLAMMATORY CYTOKINES AND INCREASES SOLUBLE HLA PLASMA-LEVELS IN HUMANS, Blood, 90(10), 1997, pp. 423-423
Authors:
ELMAAGACLI AH
BEELEN DW
BECKS HW
MOBASCHER A
STOCKOVA J
TRZENSKY S
OPALKA B
SCHAEFER UW
Citation: Ah. Elmaagacli et al., MOLECULAR STUDIES OF CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL OR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(2), 1996, pp. 397-403
Authors:
SCHEULEN B
JOHNMIKOLAJEWSKI V
BECKS HW
BEELEN DW
SCHAEFER UW
Citation: B. Scheulen et al., UNUSUAL DIFFERENTIAL-DIAGNOSIS OF FREE IN TRAABDOMINAL AIR - PNEUMATOSIS-CYSTOIDES-INTESTINALIS, Der Internist, 37(12), 1996, pp. 1260-1264
Authors:
OTTINGER HD
BEELEN DW
SCHEULEN B
SCHAEFER UW
GROSSEWILDE H
Citation: Hd. Ottinger et al., IMPROVED IMMUNE RECONSTITUTION AFTER ALLOTRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELLS INSTEAD OF BONE-MARROW, Blood, 88(7), 1996, pp. 2775-2779
Citation: Ah. Elmaagacli et al., COMPARISON OF THE INCIDENCE OF HOST-TYPE HEMATOPOIESIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER SEX MISMATCHED, NON-T-CELL DEPLETED, ALLOGENEIC BONE-MARROWTRANSPLANTATION (BMT), Experimental hematology, 23(8), 1995, pp. 854-854
Authors:
ELMAAGACLI AH
BECKS HW
BEELEN DW
STOCKOVA J
BUTZLER R
OPALKA B
SCHAEFER UW
Citation: Ah. Elmaagacli et al., DETECTION OF MINIMAL RESIDUAL DISEASE AND PERSISTENCE OF HOST-TYPE HEMATOPOIESIS - A STUDY IN 28 PATIENTS AFTER SEX-MISMATCHED, NON-T CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 16(6), 1995, pp. 823-829
Authors:
BEELEN DW
GRAEVEN U
ELMAAGACLI AH
NIEDERLE N
KLOKE O
OPALKA B
SCHAEFER UW
Citation: Dw. Beelen et al., PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME, Blood, 85(10), 1995, pp. 2981-2990
Citation: Dw. Beelen et Uw. Schaefer, PRESENT INDICATIONS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES WITH HIGH-DOSE RADIOCHEMOTHERAPY AND ALLOGENEIC OR AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT, Tumordiagnostik & Therapie, 15(6), 1994, pp. 207-228
Authors:
LIEDTKE W
QUABECK K
BEELEN DW
STRAETEN V
SCHAEFER UW
Citation: W. Liedtke et al., RECURRENT ACUTE INFLAMMATORY DEMYELINATING POLYRADICULITIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of the neurological sciences, 125(1), 1994, pp. 110-111
Authors:
OTTINGER HD
SAYER H
BEELEN DW
SCHAEFER UW
GROSSEWILDE H
Citation: Hd. Ottinger et al., BONE-MARROW TRANSPLANTATION FROM HLA-PARTIALLY MATCHED RELATED DONORSIN ADULTS WITH LEUKEMIA, Blood, 84(10), 1994, pp. 10000716-10000716
Authors:
DIEKMANN L
BEELEN DW
QUABECK K
BECHER R
HOLTHAUSEN HS
BUTZLER R
SCHAEFER UW
OPALKA B
Citation: L. Diekmann et al., PRESENCE OR RE-APPEARANCE OF BCR-ABL-POSITIVE CELLS YEARS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA IN PATIENTS IN HEMATOLOGICAL REMISSION, Acta haematologica, 92(4), 1994, pp. 169-175